Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenzhuo Decoction in Diabetic Kidney Disease
NCT07034807Not yet recruiting
- Start
- Aug 2025
- Primary completion
- Jul 2028
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, open-label trial of Shenzhuo Decoction in diabetic kidney disease (DKD) (2 arms). Primary endpoint: Glomerular filtration rate decline slope at 24 months. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Shenzhuo Decoction
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT07034807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07034807.